Novartis Unit Subpoenaed In HHS Fraud Investigation
The department launched the civil investigation into Alcon's marketing practices and payments to health care providers on Sept. 23, Novartis said in its third-quarter earnings report. The subpoena requested information regarding Alcon's surgical equipment and ophthalmic medications Vigamox, Nevanac, Omnipred and Econopred.
"The subpoena requests the production of documents relating to the marketing practices...
To view the full article, register now.